EASD 2019: Exenatide + SGLT2 Inhibition May Improve Renal Function and All-Cause Mortality in Type 2 Diabetes
The combination improved estimated GFR vs exenatide alone.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.